Packer M et al., SUMMIT, NEJM 2024 (NEJMoa2410027, PMID 39555826) : tirzepatide and HFpEF with obesity, HR 0,62 composite endpoint
In some of such embodiments, a micronized therapeutic agent comprising micronized particles, coated micronized particles, or a combination thereof, comprises a therapeutic agent as a free base, a salt, a prodrug or any combination thereof
If it produces and sells 2,000 units, total cost is $350,000 [= $50,000 + (2,000 $150)]
This actin-binding activity is crucial for regulating cellular motility, wound healing, and tissue repair processes
The peptide also modulates inflammatory pathways by inhibiting pro-inflammatory cytokines, which helps in reducing swelling and preventing further joint damage